KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Revenue (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Revenue readings, the most recent being $11.0 billion for Q1 2026.

  • On a quarterly basis, Revenue rose 6.18% to $11.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $45.2 billion, a 5.36% increase, with the full-year FY2025 number at $44.6 billion, up 3.91% from a year prior.
  • Revenue hit $11.0 billion in Q1 2026 for Thermo Fisher Scientific, down from $12.2 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $12.2 billion in Q4 2025 to a low of $10.3 billion in Q1 2024.
  • Median Revenue over the past 5 years was $10.9 billion (2025), compared with a mean of $11.0 billion.
  • Biggest five-year swings in Revenue: grew 19.3% in 2022 and later decreased 9.38% in 2023.
  • Thermo Fisher Scientific's Revenue stood at $11.5 billion in 2022, then dropped by 4.93% to $10.9 billion in 2023, then increased by 4.68% to $11.4 billion in 2024, then grew by 7.2% to $12.2 billion in 2025, then fell by 9.91% to $11.0 billion in 2026.
  • The last three reported values for Revenue were $11.0 billion (Q1 2026), $12.2 billion (Q4 2025), and $11.1 billion (Q3 2025) per Business Quant data.